Dashboard
Manage Tickers

CYTH Cyclo Therapeutics, Inc.

Nasdaq cyclotherapeutics.com


$ 0.01 (1.39 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 612.11 $ 7.61 (1.26 %)
DIA $ 467.12 $ 5.24 (1.13 %)
SPY $ 671.75 $ 6.91 (1.04 %)
TLT $ 91.68 $ 0.35 (0.38 %)
GLD $ 401.36 $ 14.16 (3.64 %)
$ 0.7206
-- x --
-- x --
-- - --
$ 0.55 - $ 1.79
188,267
na
20.69M
$ -0.59
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-14-2024 09-30-2024 10-Q
2 08-14-2024 06-30-2024 10-Q
3 05-15-2024 03-31-2024 10-Q
4 03-18-2024 12-31-2023 10-K
5 11-14-2023 09-30-2023 10-Q
6 08-14-2023 06-30-2023 10-Q
7 05-12-2023 03-31-2023 10-Q
8 03-17-2023 12-31-2022 10-K
9 11-10-2022 09-30-2022 10-Q
10 08-15-2022 06-30-2022 10-Q
11 05-12-2022 03-31-2022 10-Q
12 03-11-2022 12-31-2021 10-K
13 11-15-2021 09-30-2021 10-Q
14 08-16-2021 06-30-2021 10-Q
15 05-14-2021 03-31-2021 10-Q
16 03-12-2021 12-31-2020 10-K
17 11-12-2020 09-30-2020 10-Q
18 08-14-2020 06-30-2020 10-Q
19 05-15-2020 03-31-2020 10-Q
20 03-30-2020 12-31-2019 10-K
21 11-14-2019 09-30-2019 10-Q
22 08-13-2019 06-30-2019 10-Q
23 05-15-2019 03-31-2019 10-Q
24 03-15-2019 12-31-2018 10-K
25 11-09-2018 09-30-2018 10-Q
26 08-14-2018 06-30-2018 10-Q
27 05-15-2018 03-31-2018 10-Q
28 04-16-2018 12-31-2017 10-K
29 11-09-2017 09-30-2017 10-Q
30 08-11-2017 06-30-2017 10-Q
31 05-12-2017 03-31-2017 10-Q
32 03-17-2017 12-31-2016 10-K
33 11-10-2016 09-30-2016 10-Q
34 08-12-2016 06-30-2016 10-Q
35 05-16-2016 03-31-2016 10-Q
36 03-30-2016 12-31-2015 10-K
37 11-12-2015 09-30-2015 10-Q
38 08-14-2015 06-30-2015 10-Q
39 05-15-2015 03-31-2015 10-Q
40 03-27-2015 12-31-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
03/25/2025 12:10:17

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
03/20/2025 21:06:20

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
02/10/2025 21:05:43

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
02/10/2025 12:05:39

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
02/07/2025 21:05:49

cyclo-therapeutics-presents-preliminary-data-from-phase-3-transportnpc-study-of-trappsol-with-6-of-7-patients-showing-stabilization-or-improvement-in-clinical-global-impression-over-48-weeks-topline-48-week-interim-data-expected-in-h1-2025
Cyclo Therapeutics Presents Preliminary Da...
02/07/2025 13:09:55

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
12/04/2024 21:06:10

cyclo-therapeutics-q3-eps-031-misses-016-estimate-sales-23377k-miss-29400k-estimate
Cyclo Therapeutics Q3 EPS $(0.31) Misses $...
11/14/2024 13:38:06

Cyclo Therapeutics (NASDAQ:CYTH) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of ...

cyclo-therapeutics-shares-are-trading-higher-after-the-company-announced-the-presentation-of-preliminary-data-from-its-ongoing-pivotal-phase-3-study-and-substudy-evaluating-trappsol-cyclo-for-the-treatment-of-niemann-pick-disease-type-c1
Cyclo Therapeutics shares are trading high...
09/05/2024 13:09:01

cyclo-therapeutics-presents-preliminary-data-from-phase-3-study-of-trappsol-cyclo-for-niemann-pick-disease-type-c1-at-ssiem-symposium-topline-data-expected-h1-2025
Cyclo Therapeutics Presents Preliminary Da...
09/05/2024 13:06:33

this-hershey-analyst-turns-bearish-here-are-top-5-downgrades-for-tuesday
This Hershey Analyst Turns Bearish; Here A...
08/27/2024 13:00:52

maxim-group-downgrades-cyclo-therapeutics-to-hold
Maxim Group Downgrades Cyclo Therapeutics ...
08/27/2024 12:32:28

Maxim Group analyst Jason McCarthy downgrades Cyclo Therapeutics (NASDAQ:CYTH) from Buy to Hold.

ascendiant-capital-maintains-buy-on-cyclo-therapeutics-lowers-price-target-to-095
Ascendiant Capital Maintains Buy on Cyclo ...
08/26/2024 10:10:17

Ascendiant Capital analyst Lucas Ward maintains Cyclo Therapeutics (NASDAQ:CYTH) with a Buy and lowers the price target from...

hc-wainwright--co-downgrades-cyclo-therapeutics-to-neutral-lowers-price-target-to-095
HC Wainwright & Co. Downgrades Cyclo Thera...
08/23/2024 11:23:33

HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Cyclo Therapeutics (NASDAQ:CYTH) from Buy to Neutral and l...

nasdaq-down-over-200-points-williams-sonoma-shares-tumble-after-q2-results
Nasdaq Down Over 200 Points; Williams-Sono...
08/22/2024 18:47:30

gold-down-over-1-us-initial-jobless-claims-increase
Gold Down Over 1%; US Initial Jobless Clai...
08/22/2024 16:16:23

dow-jumps-100-points-bjs-wholesale-earnings-top-estimates
Dow Jumps 100 Points; BJ's Wholesale Earni...
08/22/2024 13:54:09

Core News & Articles
Rafael And Cyclo Therapeutics Have Agreed ...
08/22/2024 10:52:33

On consummation of the merger, Rafael will issue Class B shares to Cyclo Therapeutics' shareholders, based on an exchange r...

hc-wainwright--co-reiterates-buy-on-cyclo-therapeutics-maintains-3-price-target
HC Wainwright & Co. Reiterates Buy on Cycl...
08/16/2024 16:12:53

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Cyclo Therapeutics (NASDAQ:CYTH) with a Buy and maintains ...

cyclo-therapeutics-q2-eps-021-misses-016-estimate-sales-12310k-miss-26750k-estimate
Cyclo Therapeutics Q2 EPS $(0.21) Misses $...
08/15/2024 13:03:11

Cyclo Therapeutics (NASDAQ:CYTH) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION